Attorney Joins the Vaccine & Gene Therapy Institute of Florida Board of Directors
News Feb 28, 2013
Mr. Lord is Senior Vice President, Legal Services and Chief Legal Officer of Martin Health System, which serves the residents of Florida’s Treasure Coast. He is currently overseeing the construction and development of the new Martin Health System Campus located adjacent to VGTI Florida in the Tradition Center for Innovation in Port St. Lucie, Florida.
Many opportunities exist for collaboration between the lifesaving research of VGTI Florida researchers and the clinical trials conducted by doctors at Martin Health System. Both organizations are helping to improve the lives of people locally and around the world.
A board certified health law expert and healthcare executive, Mr. Lord is an administrator in Martin Health overseeing matters ranging from operations, corporate compliance, risk management and planning to litigation and governmental relations. He has been a resident of the Treasure Coast since 1969.
“We welcome Robert’s wide ranging health law background and his wealth of experience to the VGTI Florida Board of Directors,” said Jay Nelson, Ph.D., founder and Executive Director of the institute. “He has his finger on the pulse of the local community and will contribute greatly to the progress of VGTI Florida’s research translation into the clinical environments.”
Prior to joining Martin Health System, Mr. Lord was Shareholder in the law firm of Crary, Buchanan, Bowdish, Bovie, Lord & Roby, Chartered. His practice focused on both health and media law. Prior to specializing in media and health law, he had many years of experience as a civil trial attorney.
Mr. Lord holds a Bachelor of Science from Florida State University and he received his Juris Doctorate degree from Stetson University College of Law. He is board certified by The Florida Bar in Health Law and is a Fellow of the American College of Healthcare Executives.
His professional affiliations include The Florida Bar, American Health Lawyers Association, American College of Healthcare Executives, the bars of the Florida Supreme Court and the United States Supreme Court.
Induced Pluripotent Stem Cells Could Serve as Cancer VaccineNews
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a study in mice suggests another use for iPS cells: training the immune system to attack or even prevent tumors.READ MORE
Timing of Measles Vaccine Important for Overall Child Survival RatesNews
In the largest study to date on children in a low/middle income country, research finds that the timing of a measles vaccine in an overall vaccination schedule can have a profound impact on child survival rates beyond protecting against measles infection.READ MORE